[New therapeutic strategies with teicoplanin]

Related Experiment Video

Updated: Sep 28, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Edith Carbone1, Francisco Nacinovich, Daniel Stamboulian

  • 1Fundación del Centro de Estudios Infectológicos (FUNCEI), French 3037, 1425 Buenos Aires, Argentina.

Medicina
|December 17, 2002
PubMed

Insights

Teicoplanin, a glycopeptide antibiotic, offers effective treatment for challenging infections like those caused by methicillin-resistant staphylococci. Its long half-life allows convenient dosing and improved cost-effectiveness for extended therapies, including outpatient settings.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Antimicrobial Resistance

Context:

  • Teicoplanin is a glycopeptide antibiotic with a spectrum of activity comparable to vancomycin.
  • Its long half-life (88–182 hours) permits once-daily intravenous (IV) or intramuscular (IM) administration.
  • This pharmacokinetic profile is advantageous for infections necessitating prolonged antimicrobial treatment.

Purpose:

  • To evaluate the efficacy and cost-effectiveness of teicoplanin in treating specific infections.
  • To explore teicoplanin's utility in extended antimicrobial therapy regimens, including outpatient settings.
  • To assess the potential for synergistic effects and chronic suppressive therapy with teicoplanin.

Summary:

  • Long-term teicoplanin treatment has demonstrated effectiveness against bone and joint infections caused by methicillin-resistant staphylococci.
  • Administering teicoplanin three times weekly shows comparable clinical efficacy to daily dosing, with significant cost-effectiveness improvements.
  • Teicoplanin can be combined with other antibiotics for synergistic effects and may serve as a chronic suppressive therapy option for select patients, especially those with prosthetic devices.

Impact:

  • Teicoplanin presents a viable therapeutic option for difficult-to-treat bacterial infections, particularly those involving resistant pathogens.
  • The drug's dosing convenience and cost-effectiveness enhance its suitability for prolonged outpatient antibiotic therapy.
  • Teicoplanin's role in managing chronic infections and its potential for combination therapy warrant further consideration in clinical practice.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...